Sangui BioTech International, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 10/19/2017
Contact Info
  • Alfred Herrhausen Street 44
  • Witten 58455
  • Germany

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001104280
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: CO, USA
Year of Inc. 1997
Employees 1 a/o Oct 17, 2017
Company Officers/Contacts
Thomas Striepe CEO
Company Directors
Hubertus Schmelz
Thomas Striepe
Company Notes
  • Formerly=Citadel Investments Systems, Inc. until 8-97
Service Providers
Accounting/Auditing Firm
Sadler, Gibb & Associates, LLC
2455 E. Parleys Way
Suite 320
Salt Lake City, UT, 84109
United States

Legal Counsel
Chachas Law Group P.C.
11682 El Camino Real.
Suite 100
San Diego, CA, 92130
United States

Investor Relations Firm
Fleing Kommunikation
Am Vogelherd 43
Marburg, 35043

SGBI Security Details
Share Structure
Market Value1 $14,980,920 a/o Nov 22, 2017
Authorized Shares 250,000,000 a/o Nov 22, 2017
Outstanding Shares 187,261,503 a/o Nov 22, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 167,483,902 a/o May 17, 2017
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Corporate Stock Transfer, Inc.
Shareholders of Record 891 a/o Oct 16, 2017
Short Selling Data
Short Interest 44 (0%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security